Gene testing doesn't increase anxiety, depression in children of people with Alzheimer'sJune 24, 2005BU medical researcher indicates facts satisfy need-to-know for financial, care decisions (Boston) - Adult children of people with Alzheimer's disease were satisfied and unharmed by the experience of genetic risk assessment, even when results suggested they might be at risk, according to new findings presented by Robert C. Green at the recent International Conference on the Prevention of Dementia, sponsored by the Alzheimer's Association. Green, a medical doctor and professor of neurology at Boston University School of Medicine, led the team that conducted the study. The study focused on the psychological and behavioral impact of testing for the well-known risk marker for Alzheimer's disease, ApoE4, one form of the apolipoprotein E (APOE) gene. When the team compared data from participants who had been told they were either positive or negative for ApoE4 with those from participants who had not had their ApoE4 status disclosed to them, the researchers found no significant difference in tests for depression and anxiety. Moreover, 95 percent of participants reported that they would choose risk assessment again and 82 percent would recommend risk assessment to family or friends. "As new treatments are developed to delay the onset of Alzheimer's, it is going to be critical to identify those at greatest risk," says Green. "At the same time, it will be very important that genetic risk assessment is done carefully and communicated accurately so individuals feel empowered by the results and are able to maintain a positive outlook and a good quality of life." For the study, the researchers randomized 162 study participants from Boston into two groups - one received assessment based on age, family history, gender, and disclosed APOE genotype; and one received assessment based only on age, family history and gender. After one year, the team found no significant differences among the groups (ApoE4 positive, ApoE4 negative, or no disclosure) when assessing them using the Center for Epidemiological Studies' Depression Scale and Beck Anxiety Inventory. Those in the study who tested positive for ApoE4 and were alerted to their genetic status were 5.8 times more likely to have altered their long-term care insurance than individuals who did not receive genotype disclosure. "The study suggests that people who are armed with useful information about their possible future healthcare needs will take steps to protect themselves financially," says Green. According to Green and his team of researchers, the REVEAL study (Risk Evaluation and Education for Alzheimer's disease) is the first randomized trial to examine the impact of providing risk assessment - including APOE gene marker disclosure - for Alzheimer's disease. Their study was supported by the National Human Genome Research Institute and the National Institute on Aging of the National Institutes of Health. Boston University |
|||||||||||||||||||||
| Related Risk Assessment Current Events and Risk Assessment News Articles Knocking nanoparticles off the socks Scientists in Switzerland are reporting results of one of the first studies on the release of silver nanoparticles from laundering those anti-odor, anti-bacterial socks now on the market. World interest in Australian fishery impact test An Australian method for assessing the environmental impact of marine fisheries has caught the eye of fishery management agencies worldwide. Experts unveil new CVD guidelines and position papers Several new guidelines and position papers offering the most up to date information to ensure that clinicians practice evidence-based medicine were released at the Canadian Cardiovascular Congress 2009 this week. M. D. Anderson redefines screening guidelines for breast, cervical and colorectal cancers Drawing on years of experience in cancer research and patient care, The University of Texas M. D. Anderson Cancer Center released today the most comprehensive, risk-based screening guidelines publicly available to date for breast, cervical and colorectal cancers. Redefining obesity's health risks The body mass index (BMI) has long been the yardstick in deciding who is at risk because of their weight. BMI is essentially a measure of density, identifying 'under-' and 'over-weight' risk groups. Paradigm shift needed to combat drug resistance When people travel, bacteria and other infectious agents travel with them. As about a billion people cross international borders each year, many more billions of the bugs come along for the ride. Report Documents the Risks of Giant Invasive Snakes in the U.S. Five giant non-native snake species would pose high risks to the health of ecosystems in the United States should they become established here, according to a U.S. Geological Survey (USGS) report released today. Securing biological select agents and toxins will require developing a culture of trust The most effective way to prevent the deliberate misuse of biological select agents and toxins (BSATs) -- agents housed in laboratories across the U.S. considered to potentially pose a threat to human health -- is to instill a culture of trust and responsibility in the laboratory. New ways to predict violent behavior? In the future, diagnosing severe personality disorders, evaluating the childhood environment, assessing alcohol consumption and the analysis of the MAOA genotype may provide more accurate means for assessing risk among violent offenders, according to the Finnish research carried out jointly at the University of Helsinki and the Helsinki University Central Hospital Psychiatry Centre. Many Australians at risk of cardiovascular disease are not receiving best practice care Many people are not receiving the best possible care when it comes to managing cardiovascular conditions according to two new Australian research studies. More Risk Assessment Current Events and Risk Assessment News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||